Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (25)

Advertisement

Research Article Free access | 10.1172/JCI114922

Prostaglandin protects isolated guinea pig chief cells against ethanol injury via an increase in diacylglycerol.

Y Konda, H Nishisaki, O Nakano, K Matsuda, K Wada, M Nagao, T Matozaki, and C Sakamoto

Second Department of Internal Medicine, Kobe University School of Medicine, Japan.

Find articles by Konda, Y. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, Kobe University School of Medicine, Japan.

Find articles by Nishisaki, H. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, Kobe University School of Medicine, Japan.

Find articles by Nakano, O. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, Kobe University School of Medicine, Japan.

Find articles by Matsuda, K. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, Kobe University School of Medicine, Japan.

Find articles by Wada, K. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, Kobe University School of Medicine, Japan.

Find articles by Nagao, M. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, Kobe University School of Medicine, Japan.

Find articles by Matozaki, T. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, Kobe University School of Medicine, Japan.

Find articles by Sakamoto, C. in: JCI | PubMed | Google Scholar

Published December 1, 1990 - More info

Published in Volume 86, Issue 6 on December 1, 1990
J Clin Invest. 1990;86(6):1897–1903. https://doi.org/10.1172/JCI114922.
© 1990 The American Society for Clinical Investigation
Published December 1, 1990 - Version history
View PDF
Abstract

We studied cellular processes activated by prostaglandins (PG) that are involved in the protection of gastric chief cell injury estimated in terms of dye exclusion test, release of lactate dehydrogenase (LDH), or 51Cr from prelabeled chief cells. Pretreatment of chief cells with 3 x 10(-6) M PGE2 or PGE1 at 37 degrees C and pH 7.4 for 15 min maximally reduced not only ethanol- but also taurocholic acid-caused LDH release from chief cells. PGs equipotently stimulated increases in the accumulation of diacylglycerol and cyclic AMP without elevating intracellular Ca2+ concentrations in gastric chief cells. The rank order of the potency was equal to that of PGs to reduce the injury. Pretreatment of chief cells with synthetic 1-oleoyl-2-acetyl-sn-glycerol (OAG) or 12-o-tetradecanoyl phorbol 13-acetate (TPA) reduced the injury of chief cells, while 4 alpha-phorbol 12,13-didecanoate, an inactive phorbol ester, failed to reduce the injury and 1-(5-isouinolinylsulfonyl)-2-methylpiperazine (H7) blocked the protective action of PGE2. On the other hand, forskolin and dbcAMP had no effect on ethanol-caused LDH release and diacylglycerol formation in chief cells. These results suggest that PGE2 and PGE1 possess the direct protective action against ethanol- or taurocholic acid-caused injury in chief cells, presumably through the activation of the diacylglycerol/protein kinase C signaling pathway.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1897
page 1897
icon of scanned page 1898
page 1898
icon of scanned page 1899
page 1899
icon of scanned page 1900
page 1900
icon of scanned page 1901
page 1901
icon of scanned page 1902
page 1902
icon of scanned page 1903
page 1903
Version history
  • Version 1 (December 1, 1990): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (25)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts